Top Markets
Coin of the day
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.

Genovate Biotechnology Co., Ltd.

4130
Rank in Stocks #21465
Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the... Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the research, development, production, and commercialization of various products. These offerings primarily aim to prevent and treat illnesses resulting from viral and bacterial infections. The company's diverse portfolio extends to drugs, active pharmaceutical ingredients (APIs), intermediates, and specialized release agents, which are crucial for addressing a range of health issues including cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune conditions. Complementing its pharmaceutical offerings, Genovate also manufactures controlled-release Western medicine formulations and cosmetic items. Established in 1982, the company's operations are headquartered in Hsinchu City, Taiwan.
Share Price
$0.84903405
Last synced: 2026-07-27
Market Cap
$106.63M
Change (1 day)
0.00%
Change (1 year)
38.69%
Country
TW
Trade Genovate Biotechnology Co., Ltd. (4130)

Category

P/S ratio for Genovate Biotechnology Co., Ltd. (4130)
P/S ratio as of 2026 TTM: 0
According to Genovate Biotechnology Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Genovate Biotechnology Co., Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH